See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-104. Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Presenter: Ian Meredith

October 23, 2012

Presentation TCT 2012

Overview 2: Biological Therapies for Heart Failure: Regulatory Perspectives

Presenter: Steve Winitsky

October 23, 2012

Presentation TCT 2012

From Access to the Coronaries: Strategies for Success and Troubleshooting

Presenter: Douglas Fraser

October 23, 2012

Presentation TCT 2012

TCT-61. Infarct Size-Determined Uptake of CD34+ Cells in the Peri-Infarct Zone and Left Ventricular Remodeling: Insights from Integration of Labeled Cells Uptake SPECT...

Presenter: Piotr Musialek

October 23, 2012

Presentation TCT 2012

ACP Tips and Tricks

Presenter: David Muller

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

Presenter: Ajay Kirtane

October 23, 2012

Presentation TCT 2012

PCSK9 Inhibitors: The Holy Grail?

Presenter: Evan Stein

October 23, 2012

Presentation TCT 2012

Concurrent Coronary Artery and Valvular Heart Disease 2: Hybrid PCI with Transcatheter Valves

Presenter: Jean-Michel Paradis

October 23, 2012

Presentation TCT 2012

Appropriateness Criteria: Implications for Clinical Practice

Presenter: Monica Losquadro

October 23, 2012

Presentation TCT 2012

Cre8 (CID) Program Update

Presenter: Didier Carri?

October 23, 2012

Advertisement

Slides

TCT-104. Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Overview 2: Biological Therapies for Heart Failure: Regulatory Perspectives

From Access to the Coronaries: Strategies for Success and Troubleshooting

TCT-61. Infarct Size-Determined Uptake of CD34+ Cells in the Peri-Infarct Zone and Left Ventricular Remodeling: Insights from Integration of Labeled Cells Uptake SPECT...

ACP Tips and Tricks

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

PCSK9 Inhibitors: The Holy Grail?

Concurrent Coronary Artery and Valvular Heart Disease 2: Hybrid PCI with Transcatheter Valves

Appropriateness Criteria: Implications for Clinical Practice

Cre8 (CID) Program Update

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content